GeneThera, Inc. (GTHR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 5280.00 | 5280.00 | 5280.00 | 5280.00 | - |
| Gross Profit | - | -5280.00 | -5280.00 | -5280.00 | -5280.00 | - |
| Operating Expenses | - | 1 Million | 740.61 Thousand | 739.15 Thousand | 3.92 Million | 605.7 Thousand |
| Selling, General and Administrative Expenses | - | 1 Million | 740.61 Thousand | 739.15 Thousand | 3.92 Million | 605.7 Thousand |
| Research and Development Expenses | - | - | - | - | 180 Thousand | - |
| Other Expenses | - | 466 Thousand | 466 Thousand | 250.08 Thousand | 3.39 Million | 567.99 Thousand |
| Cost and Expenses | - | 1 Million | 740.61 Thousand | 739.15 Thousand | 3.92 Million | 605.7 Thousand |
| Operating Income | - | -1 Million | -740.61 Thousand | -739.15 Thousand | -3.92 Million | -605.7 Thousand |
| Interest Expense | - | 2224.00 | 33.85 Thousand | 28.58 Thousand | 117.97 Thousand | 146.62 Thousand |
| Income Tax Expense | - | 2224.00 | 33.85 Thousand | 28.58 Thousand | -1.00 | 152.02 Thousand |
| Earnings before Tax | - | -1.01 Million | -774.46 Thousand | -517.65 Thousand | -4.04 Million | -757.72 Thousand |
| Net Income | - | -1.01 Million | -808.31 Thousand | -546.23 Thousand | -4.04 Million | -757.72 Thousand |
| Earnings Per Share Basic | - | -0.04 | -0.04 | -0.02 | -0.11 | -0.02 |
| Earnings Per Share Diluted | - | -0.04 | -0.04 | -0.02 | -0.11 | -0.02 |
| Weighted Average Shares Outstanding | - | 25.35 Million | 20.31 Million | 35.9 Million | 38.19 Million | 40.06 Million |
| Weighted Average Shares Outstanding (Diluted) | - | 25.35 Million | 20.31 Million | 35.9 Million | 38.19 Million | 40.06 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | -1 Million | -735.33 Thousand | -733.87 Thousand | -3.92 Million | -152.02 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | 1320.00 |
| Gross Profit | - | - | - | - | - | -1320.00 |
| Operating Expenses | - | - | - | - | - | 125.01 Thousand |
| Selling, General and Administrative Expenses | - | - | - | - | - | 123.69 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | 1320.00 |
| Cost and Expenses | - | - | - | - | - | 125.01 Thousand |
| Operating Income | - | - | - | - | - | -125.01 Thousand |
| Interest Expense | - | - | - | - | - | 556.00 |
| Income Tax Expense | - | - | - | - | - | 556.00 |
| Earnings before Tax | - | - | - | - | - | -125.57 Thousand |
| Net Income | - | - | - | - | - | -126.12 Thousand |
| Earnings Per Share Basic | - | - | - | - | - | -0.00 |
| Earnings Per Share Diluted | - | - | - | - | - | -0.00 |
| Weighted Average Shares Outstanding | - | - | - | - | - | 34.2 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | - | - | 34.2 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | -123.69 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
FMBRY
ANGO
PCTN
XCHANGING
JCK
OPAL